Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery: A retrospective review

European Journal of Anaesthesiology

Volumn 31, Issue 6, 2014, Pages 317-326

  Faraoni, David ^a   Willems, Ariane ^a   Savan, Veaceslav ^b   Demanet, Helene ^a   De Ville, Andree ^a   Van Der Linden, Philippe ^a  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^b International Hospital Medpark   (Moldova)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; PROTAMINE; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD CLOTTING; BLOOD VOLUME; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART SURGERY; HOSPITALIZED CHILD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PEDIATRIC SURGERY; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SURGICAL PATIENT; THROMBOELASTOGRAPH; WOUND CLOSURE; BLOOD; BLOOD TRANSFUSION; METABOLISM; MORTALITY; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; THROMBOELASTOGRAPHY; TREATMENT OUTCOME;

BLOOD COAGULATION; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CHILD, PRESCHOOL; FEMALE; FIBRINOGEN; HUMANS; INFANT; MALE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; THROMBELASTOGRAPHY; TREATMENT OUTCOME;

EID: 84902143432     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000043     Document Type: Article

References (38)

1. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004; 30:1873- 1881. (Pubitemid 39468407)
2. Levy JH, Tanaka KA, Steiner ME. Evaluation and management of bleeding during cardiac surgery. Curr Hematol Rep 2005; 4:368-372.
3. Petaja J, Lundstrom U, Leijala M, et al. Bleeding and use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 1995; 109:524-529.
4. Guzzetta NA. Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery. Paediatr Anaesth 2011; 21:504- 511.
5. Guzzetta NA, Miller BE. Principles of hemostasis in children: models and maturation. Paediatr Anaesth 2011; 21:3-9.
6. Hayashi T, Sakurai Y, Fukuda K, et al. Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery. Paediatr Anaesth 2011; 21:865-871.
7. Gorlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115:1179-1191.
8. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117:531-547.
9. Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149:834-843.
10. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10:1342-1351.
11. Rahe-Meyer N, Solomon C, Winterhalter M, et al. Thromboelastometryguided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009; 138:694-702.
12. Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013; 118:40-50.
13. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, et al. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101:769-773.
14. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17:R76.
15. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382.
16. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17:237-246.
17. Jenkins KJ, Gauvreau K, Newburger JW, et al. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002; 123:110-118.
18. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999; 89:57-64. (Pubitemid 29293309)
19. Blome M, Isgro F, Kiessling AH, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005; 93:1101-1107. (Pubitemid 40823515)
20. Solomon C, Hagl C, Rahe-Meyer N. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery. Br J Anaesth 2013; 110:947-956.
21. Ranucci M. Fibrinogen supplementation in cardiac surgery: where are we now and where are we going? J Cardiothorac Vasc Anesth 2013; 27:1-4.
22. Chowdary P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125:69-73. (Pubitemid 38453280)
23. Rahe-Meyer N, Pichlmaier M, Haverich A, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009; 102:785-792.
24. Kozek-Langenecker S, Sorensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011; 15:R239.
25. Rugeri L, Levrat A, David JS, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5:289-295. (Pubitemid 46139453)
26. Solomon C, Cadamuro J, Ziegler B, et al. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion 2011; 51:1695- 1706.
27. Haas T, Spielmann N, Mauch J, et al. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108:36-41.
28. Levy JH, Faraoni D, Sniecinski RM. Perioperative coagulation management in the intensive care unit. Curr Opin Anaesthesiol 2013; 26:65-70.
29. Osthaus WA, Boethig D, Johanning K, et al. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis 2008; 19:220- 225. (Pubitemid 351498726)
30. Kozek-Langenecker SA. Influence of fluid therapy on the haemostatic system of intensive care patients. Best Pract Res Clin Anaesthesiol 2009; 23:225-236.
31. Innerhofer P, Fries D, Margreiter J, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002; 95:858-865.
32. Haas T, Fries D, Holz C, et al. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution. Anesth Analg 2008; 106:1078-1086. (Pubitemid 351450529)
33. Adam S, Karger R, Kretschmer V. Influence of different hydroxyethyl starch (HES) formulations on fibrinogen measurement in HES-diluted plasma. Clin Appl Thromb Hemost 2010; 16:454-460.
34. Hanart C, Khalife M, De Ville A, et al. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 2009; 37:696-701.
35. Van der Linden P, De Ville A, Hofer A, et al. Six percent hydroxyethyl starch 130/0.4 (Voluven) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology 2013; [Epub ahead of print].
36. Van der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013; 116:35-48.
37. Willems A, Faraoni D, De Ville A, Van der Linden P. Does the volume of tetrastarch administered intra-operatively influence postoperative blood loss in children undergoing cardiac surgery? Transfus Med 2013; 23 (Suppl 1):16-46.
38. Hofer A, Kozek-Langenecker S, Schaden E, et al. Point-of-care assessment of platelet aggregation in paediatric open heart surgery. Br J Anaesth 2011; 107:587-592.